Neovascular Age Related Macular Degeneration Amd clinical trials

Explore recruiting neovascular age related macular degeneration amd clinical trials.

Recruiting neovascular age related macular degeneration amd studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Neovascular Age Related Macular Degeneration Amd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An open-label, single group, single-dose clinical study to evaluate the usability of the pre-filled syringe (PFS) of SB11 in trial participants with Neovascular Age-Related Macular Degeneration (AMD), Macular Oedema Secondary to Retinal Vein Occlusion (RVO), or Myopic Choroidal Neovascularization (mCNV)

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with Aflibercept Alone, in Participants with Neovascular Age-related Macular Degeneration (nAMD)

Czechia, Bulgaria, Croatia, Netherlands, Poland, Estonia +10 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Neovascular Age Related Macular Degeneration Amd trials by city

Neovascular Age Related Macular Degeneration Amd in Toronto Neovascular Age Related Macular Degeneration Amd in Vancouver Neovascular Age Related Macular Degeneration Amd in Montreal Neovascular Age Related Macular Degeneration Amd in Calgary Neovascular Age Related Macular Degeneration Amd in Edmonton Neovascular Age Related Macular Degeneration Amd in Ottawa Neovascular Age Related Macular Degeneration Amd in Winnipeg Neovascular Age Related Macular Degeneration Amd in Quebec City Neovascular Age Related Macular Degeneration Amd in Hamilton Neovascular Age Related Macular Degeneration Amd in Kitchener Neovascular Age Related Macular Degeneration Amd in London Neovascular Age Related Macular Degeneration Amd in Halifax Neovascular Age Related Macular Degeneration Amd in New York Neovascular Age Related Macular Degeneration Amd in Los Angeles Neovascular Age Related Macular Degeneration Amd in Chicago Neovascular Age Related Macular Degeneration Amd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease